-
EP3337462
European procedure
Extract from the Register of European Patents
EP About this file: EP3337462
| EP3337462 - MELATONIN-MINITABLETTEN UND VERFAHREN ZU DEREN HERSTELLUNG [Right-click to bookmark this link] | |||
| Former [2018/26] | MELATONIN-MINITABLETTEN UND VERFAHREN ZUR HERSTELLUNG DAVON | ||
| [2020/29] | Status | No opposition filed within time limit Status updated on 06.08.2021 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 28.08.2020 | ||
| Former | Grant of patent is intended Status updated on 22.08.2020 | ||
| Former | Examination is in progress Status updated on 18.07.2020 | ||
| Former | Grant of patent is intended Status updated on 28.06.2020 | ||
| Former | Examination is in progress Status updated on 04.12.2019 | ||
| Former | Request for examination was made Status updated on 25.05.2018 | ||
| Former | The international publication has been made Status updated on 05.05.2018 | ||
| Former | unknown Status updated on 14.12.2016 | Most recent event Tooltip | 06.08.2021 | No opposition filed within time limit | published on 08.09.2021 [2021/36] | Applicant(s) | For all designated states Neurim Pharmaceuticals Ltd. 27 HaBarzel Street 6971039 Tel Aviv / IL | [2020/31] |
| Former [2018/26] | For all designated states NEURIM PHARMACEUTICALS (1991) LIMITED 27 HaBarzel Street 6971039 Tel Aviv / IL | Inventor(s) | 01 /
LAUDON, Moshe c/o Neurim Pharmaceuticals Ltd. 27 HaBarzel Street 6971039 Tel Aviv / IL | 02 /
ZISAPEL, Nava c/o Neurim Pharmaceuticals Ltd. 27 HaBarzel Street 6971039 Tel Aviv / IL | [2018/26] | Representative(s) | Weickmann & Weickmann PartmbB Postfach 860 820 81635 München / DE | [2018/26] | Application number, filing date | 16805903.8 | 29.11.2016 | [2018/26] | WO2016IB57190 | Priority number, date | US201662415014P | 31.10.2016 Original published format: US 201662415014 P | [2018/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018078429 | Date: | 03.05.2018 | Language: | EN | [2018/18] | Type: | A1 Application with search report | No.: | EP3337462 | Date: | 27.06.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.05.2018 takes the place of the publication of the European patent application. | [2018/26] | Type: | B1 Patent specification | No.: | EP3337462 | Date: | 30.09.2020 | Language: | EN | [2020/40] | Search report(s) | International search report - published on: | EP | 03.05.2018 | Classification | IPC: | A61P25/20, A61K31/4045 | [2020/29] | CPC: |
A61K31/4045 (EP,IL,KR,US);
A61K9/2072 (EP,IL,KR,US);
A61K9/0053 (KR);
A61K9/2009 (EP,IL,KR,US);
A61K9/2018 (EP,IL,KR,US);
A61K9/2027 (EP,IL,KR,US);
|
| Former IPC [2018/26] | A61K9/20 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/26] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | MELATONIN-MINITABLETTEN UND VERFAHREN ZU DEREN HERSTELLUNG | [2020/29] | English: | MELATONIN MINI-TABLETS AND METHOD OF MANUFACTURING THE SAME | [2018/26] | French: | MINI-COMPRIMÉS DE MÉLATONINE ET LEUR PROCÉDÉ DE FABRICATION | [2018/26] |
| Former [2018/26] | MELATONIN-MINITABLETTEN UND VERFAHREN ZUR HERSTELLUNG DAVON | Entry into regional phase | 22.01.2018 | National basic fee paid | 22.01.2018 | Designation fee(s) paid | 22.01.2018 | Examination fee paid | Examination procedure | 12.06.2017 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 22.01.2018 | Examination requested [2018/26] | 22.01.2018 | Date on which the examining division has become responsible | 06.09.2018 | Amendment by applicant (claims and/or description) | 09.12.2019 | Despatch of a communication from the examining division (Time limit: M04) | 19.02.2020 | Reply to a communication from the examining division | 07.04.2020 | Despatch of a communication from the examining division (Time limit: M04) | 06.05.2020 | Reply to a communication from the examining division | 29.06.2020 | Communication of intention to grant the patent | 16.07.2020 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 16.07.2020 | Fee for grant paid | 16.07.2020 | Fee for publishing/printing paid | 21.08.2020 | Information about intention to grant a patent | 21.08.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20195788.3 / EP3777842 | EP24208766.6 | Opposition(s) | 01.07.2021 | No opposition filed within time limit [2021/36] | Fees paid | Renewal fee | 14.11.2018 | Renewal fee patent year 03 | 14.11.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]EP0518468 (NEURIM PHARMA 1991 [IL]); | [A]WO9503043 (OREGON STATE [US]); | [Y]EP0724878 (NEURIM PHARMA 1991 [IL]); | [Y]WO03086352 (NEURIM PHARMACEUTICALS LTD 1991 [IL], et al); | by applicant | US6469044 |